Epstein-Barr Virus May Play Role in Multiple Sclerosis Development - The New York Times

Go to news

Scientists identify therapeutic target for Epstein-Barr virus - Science Daily

Go to news

New Study Explores EBNA1 as a Target for Epstein-Barr Virus-Positive Advanced Nasopharyngeal Carcinoma - Targeted Oncology

Go to news

Tevogen Bio™ to Study Potential Use of its T cell Technology in Epstein-Barr Virus and Multiple Sclerosis - Business Wire

Go to news

mRNA vaccine for Epstein-Barr Virus enters Phase I trial - European Pharmaceutical Review

Go to news

mRNA vaccine makers set sights on shingles and the Epstein-Barr virus - New Atlas

Go to news

Letter to the Editor: Response to Letter to the Editor by Leon W. Retief - moosejawtoday.com

Go to news

This Week In Science! - IFLScience

Go to news

Researchers simulate SARS-COV-2 transmission and infection on airline flights - Science Daily

Go to news

A future mono vaccine may have a shot at defeating multiple sclerosis, a new study suggests - Business Insider Australia

Go to news

How to predict if a patient will suffer 'long Covid' symptoms? Researchers find answer - Livemint

Go to news

The cellular response that protects pigs from COVID-19: Research could lead to new treatments in humans - Science Daily

Go to news

Is the Epstein-Barr Virus Connected with Leukemia? - Healthline

Go to news

Trial Launched to Assess Safety and Efficacy of Novel Drug in Rare Type of Head and Neck Cancer - Curetoday.com

Go to news

Epstein-Barr Virus Treatment - Verywell Health

Go to news

The Epstein–Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growth - pnas.org

Go to news

Epstein-Barr Virus: Forgotten Etiology of Hepatic Injury - Clinical Advisor

Go to news

Is there a link between long COVID and Epstein-Barr virus? - Medical News Today

Go to news

Long COVID and Severe Infections Associated with Epstein-Barr Virus Reactivation - Laboratory Equipment

Go to news

Can the Epstein-Barr virus cause leukemia? - Medical News Today

Go to news

Epstein Barr Virus T-Cell Therapy Mitigates Challenges of CAR Treatments in Lymphoma - Targeted Oncology

Go to news

Reactivation of Epstein-Barr virus might explain long COVID symptoms - Hospital Healthcare Europe

Go to news

Pharmacy Clinical Pearl of the Day: Mononucleosis - Pharmacy Times

Go to news

How Long Is Mononucleosis Contagious? - Verywell Health

Go to news

Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS? - Multiple Sclerosis News Today

Go to news

Comparison of clinical characteristics of a patient with Epstein–Barr virus‐associated seizure and patients with COVID‐19‐associated seizure - Wiley

Go to news

Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells | Journal of Virology - Journal of Virology

Go to news

Epstein–Barr virus infection associated with acute acalculous cholecystitis in a 20-year-old woman - CMAJ

Go to news

Atara Biotherapeutics: Developing personalized, off-the-shelf therapies for multiple sclerosis - BioPharma-Reporter.com

Go to news

What Is a Mono Rash? - Verywell Health

Go to news

Mono Blood Test: Uses, Side Effects, Procedure, Results - Verywell Health

Go to news

What Is Mononucleosis? - Mono Symptoms, Causes, Treatment, and Prevention - Prevention.com

Go to news

Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation | Journal of Virology - Journal of Virology

Go to news

M1 Macrophage Polarization Prevails in Epstein-Barr Virus-Infected Children in an Immunoregulatory Environment | Journal of Virology - Journal of Virology

Go to news

Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients | Journal of Virology - Journal of Virology

Go to news

Long COVID Symptoms – Such As Fatigue, Brain Fog, and Rashes – Likely Caused by Epstein-Barr Virus Reactivation - SciTechDaily

Go to news

Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study - The Lancet

Go to news

Mono and type 2 diabetes: Link, risks, effects, and more - Medical News Today

Go to news

Epstein-Barr Virus: Symptoms, Complications, Testing - Verywell Health

Go to news

12-year-old boy with yellow tongue diagnosed with Epstein-Barr virus - Know about EBV, its link with COVID-19 - Times Now

Go to news

Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas - pnas.org

Go to news

50 years ago, scientists found a virus lurking in human cancer cells - Science News

Go to news

How to Prevent the Transmission of Mononucleosis - Verywell Health

Go to news

Covid-19 treatments for people with MS - MS Trust

Go to news

Mono vs Flu: Comparing Causes, Symptoms, and Treatments - Verywell Health

Go to news

Viracta Therapeutics Initiates Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors - PRNewswire

Go to news

#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma - 2 Minute Medicine

Go to news

Treat Mononucleosis Symptoms at Home - Verywell Health

Go to news

#VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas - 2 Minute Medicine

Go to news

Management of Cytomegalovirus, Epstein-Barr Virus, and HIV Viral Load Quality Control Data Using Unity Real Time | Journal of Clinical Microbiology - Journal of Clinical Microbiology

Go to news

Viracta Therapeutics Announces Final Phase 1b/2 Data Showing Promising and Durable Signal of Efficacy for Nana-val in Relapsed/Refractory Epstein-Barr Virus-Positive Lymphoma in an Oral Presentation at ASH 2021 - PRNewswire

Go to news

For These 17 COVID Long Haulers, Reactivated Viruses May Be to Blame - Verywell Health

Go to news

Mononucleosis in youth may increase risk for MS diagnosis - Healio

Go to news

Long Covid symptoms: Epstein–Barr virus could be the cause increasing risk – what is it? - Daily Express

Go to news

Indian research sheds light on cancer-causing EBV virus - THE WEEK

Go to news

An Epstein-barr (EBV) vaccine: preventing downstream cancer risk and more.... - Cambridge Network

Go to news

Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir (Nana-val) for the Treatment of Epstein Barr Virus-Positive Diffuse Large B-cell Lymphoma - PRNewswire

Go to news

Antibody blocks Epstein-Barr virus in preclinical trial - Fred Hutch News Service

Go to news

Cell therapy promising for Epstein-Barr virus-driven post-HSCT lymphoproliferative disease - Healio

Go to news

Study of Patients With Early MS Finds Universal Positivity to Epstein-Barr Antibodies - AJMC.com Managed Markets Network

Go to news

Drug Designed To Treat Cancers Associated With Epstein–Barr Virus - Technology Networks

Go to news

Multiple Sclerosis and the Epstein-Barr Virus - Healthline

Go to news

50 years of Epstein-Barr virus - Cancer Research UK - Science Blog

Go to news

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabelecleucel for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease - Business Wire

Go to news

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More - GenomeWeb

Go to news

NIH researchers make progress toward Epstein-Barr virus vaccine - National Institutes of Health

Go to news

Key protein for Epstein-Barr virus infection - Science Daily

Go to news

Viracta Therapeutics Announces FDA Clearance of IND Application for Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors - PRNewswire

Go to news

Tenofovir prodrugs potently inhibit Epstein–Barr virus lytic DNA replication by targeting the viral DNA polymerase - pnas.org

Go to news

What Does the Epstein-Barr Virus Have to Do With Multiple Sclerosis? - Everyday Health

Go to news

Epstein-Barr virus protein can “switch on” risk genes for autoimmune diseases - National Institutes of Health

Go to news

First human antibody found to block Epstein-Barr virus - Fred Hutch News Service

Go to news

Mono: Early symptoms, risk factors, and treatment - Medical News Today

Go to news

Coronavirus deranges the immune system in complex and deadly ways - Modern Healthcare

Go to news

Why many of those struck by Long Covid may really be suffering from glandular fever - Daily Mail

Go to news

Epstein–Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters - pnas.org

Go to news

Pediatric Coinfection With Malaria and Epstein-Barr Virus - Consultant360

Go to news

Untangling How Epstein-Barr Virus Infects Cells - News Center - Northwestern University NewsCenter

Go to news

European Medicines Agency Grants Atara Biotherapeutics Accelerated Assessment of tab-cel® for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (PTLD) - Business Wire

Go to news

Epstein-Barr Virus Raises Risk of 7 Autoimmune Diseases - Verywell Health

Go to news

Roche unveils EBV immunoassay panel to detect infection stages - Medical Device Network

Go to news

Can you get mono twice? - Medical News Today

Go to news

'Mono' virus linked to seven serious diseases: Epstein-Barr virus may affect health in more ways than known - Science Daily

Go to news

How long is mono contagious? How it is spread and more - Medical News Today

Go to news

Epstein-Barr Virus in Chronic Fatigue Syndrome - Verywell Health

Go to news

Immunotherapy for Epstein-Barr: A Potential MS Treatment - Verywell Health

Go to news

Delilah Belle Hamlin Says She Has Lyme Disease, Epstein-Barr Virus, Encephalitis and PANDAS, Oh My - Gawker

Go to news

Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis - pnas.org

Go to news

Moderna Surges into 2022 with Carisma CAR-M Partnership - BioSpace

Go to news

New Genetic Research Shows How Epstein-Barr Virus Leads to Cancer - Contagionlive.com

Go to news

Mononucleosis (Mono): Overview and More - Verywell Health

Go to news

Treatments Cancer Linked to Epstein-Barr Virus - Healthline

Go to news

'Mono' virus turns on cancer-related genes. Here's how. - Livescience.com

Go to news

Need to Know: The Link Between the Epstein-Barr Virus and MS - Multiple Sclerosis News Today

Go to news

What is Mononucleosis? - News-Medical.net

Go to news

Epstein-Barr Virus May Increase Risk of MS, Other Diseases, Study... - Multiple Sclerosis News Today

Go to news

Atara Biotherapeutics Presents Positive Tab-cel® Long-Term Overall Survival Data for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant at ATC 2021 Virtual Connect - Yahoo Finance

Go to news

Experimental drug takes aim at cancers associated with Epstein-Barr virus - Science Daily

Go to news

Long COVID in Kids: The New Mono? — Eat This Not That - Eat This, Not That

Go to news

Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19 - Wiley

Go to news